跳至主要内容
临床试验/JPRN-UMIN000006959
JPRN-UMIN000006959已完成未知

The efficacy of GLP-1 receptor agonist on glycemic control in type 2 diabetes with inadequate DPP-4 inhibitor therapy. - Victoza on Inadequate Control with Sitagliptin in Juntendo and Toho

Department of Metabolism and Endocrinology, Juntendo Graduate University of Medicine0 个研究点目标入组 90 人开始时间: 2012年1月31日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
90

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1)patients who come under contraindicaion for GLP-1 receptor agonist. 2) patients who come under careful administration for GLP-1 receptor agonist 3)patients with cancer 4)anemic patients (Hb is less than 11g/dL) 5) patients with thrombocytepenia (Platelet count is less than 100000/mm3) 6) patients with serious diabetic complications including progressed neutopathy and proliferative retinopathy 7) patietns with serious infection, inflammation, or injuary. pre- or post- operative state 8) patients who are pregnant, hope to be pregnant, or are in lactation period 9) patients who are not applicable to this study judged by the medical doctor.

研究者

发起方
Department of Metabolism and Endocrinology, Juntendo Graduate University of Medicine

相似试验